New records of the archaic dolphin (Mammalia: Cetacea) from the upper Oligocene Chandler Bridge Formation of South Carolina, USA.

PeerJ

Department of Anatomy, College of Osteopathic Medicine, New York Institute of Technology, Old Westbury, NY, United States of America.

Published: September 2018

The stem odontocete (Ashley Formation, lower Oligocene, South Carolina; 29.0-26.57 Ma) has been a critical point of comparison for studies of early neocete evolution owing to its early discovery as well as its transitional anatomy relative to archaeocete whales and modern odontocetes. Some time during the late nineteenth century the holotype skull went missing and has never been relocated; supplementary reference specimens have since been recently referred to the species from the Ashley Formation and the overlying Chandler Bridge Formation (upper Oligocene; 24.7-23.5). New crania referable to sp. are identifiable to the genus based on several features of the intertemporal region. Furthermore, all published specimens from the Chandler Bridge Formation consistently share larger absolute size and a proportionally shorter exposure of the parietal in the skull roof than specimens from the Ashley Formation (including the holotype). Furthermore, these specimens include well-preserved ethmoid labyrinths and cribriform plates, indicating that primitively retained a strong olfactory sense. These new crania suggest that at least two species of are present in the Oligocene of South Carolina, revealing a somewhat more complicated taxonomic perspective.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166619PMC
http://dx.doi.org/10.7717/peerj.5290DOI Listing

Publication Analysis

Top Keywords

chandler bridge
12
bridge formation
12
south carolina
12
ashley formation
12
upper oligocene
8
oligocene south
8
formation
6
records archaic
4
archaic dolphin
4
dolphin mammalia
4

Similar Publications

Survodutide in MASH: bridging the gap between hepatic and systemic metabolic dysfunction.

Expert Opin Investig Drugs

December 2024

Department of Hepatology, The Global NASH Council, Washington, DC, USA.

Article Synopsis
  • - GLP-1 receptor agonists are effective in treating obesity and type 2 diabetes, but their ability to reverse liver fibrosis in metabolic dysfunction-associated steatohepatitis (MASH) is still uncertain; survivodutide, a dual agonist targeting both glucagon and GLP-1 receptors, shows promise in addressing these issues.
  • - This review analyzes the pharmacology, effectiveness, and safety of survodutide based on results from initial clinical trials, highlighting its potential benefits over traditional GLP-1 receptor agonists.
  • - Expert opinions suggest that survodutide’s dual action may improve outcomes for MASH patients, offering manageable side effects and a more comprehensive treatment strategy as it moves toward phase
View Article and Find Full Text PDF

Bridging biosafety and biosecurity gaps: DURC and ePPP policy insights from U.S. institutions.

Front Bioeng Biotechnol

September 2024

School for the Future of Innovation and Society, Arizona State University, Tempe, AZ, United States.

Overview: This study provides empirical data on the knowledge and practices of biosafety and biosecurity professionals and researchers involved in research on enhanced Potential Pandemic Pathogens (ePPPs) and Dual Use Research of Concern (DURC) within various U.S. sectors.

View Article and Find Full Text PDF

Background: Critical care beds are a limited resource, yet research indicates that recommendations for postoperative critical care admission based on patient-level risk stratification are not followed. It is unclear how prioritisation decisions are made in real-world settings and the effect of this prioritisation on outcomes.

Methods: This was a prespecified analysis of an observational cohort study of adult patients undergoing inpatient surgery, conducted in 274 hospitals across the UK and Australasia during 2017.

View Article and Find Full Text PDF

Site-Specific Glycosylation Analysis of Human and Murine Fcγ Receptor II Family Members Reveals Variant-Specific -Glycosylation.

J Proteome Res

August 2024

Translational Glycobiology Institute, Department of Cellular and Molecular Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida 33199, United States.

Fcγ-receptors (FcγRs) including FcγRII (CD32) gene family members are expressed on leukocytes, bind the crystallizable fragment (Fc) region of immunoglobulin G (IgG), and bridge humoral and cellular immunity. FcγRIIA and FcγRIIB have opposing roles, with the former responsible for activation and the latter for inhibition of immune cell signaling and effector functions. The extracellular domains of human and murine FcγRIIs share multiple conserved glycosylation sites.

View Article and Find Full Text PDF

Despite decades of research, acute myeloid leukemia (AML) remains a remarkably lethal malignancy. While pediatric AML (pAML) carries a more favorable prognosis than adult AML, the past 25 years of large clinical trials have produced few improvements in pAML survival. Nowhere is this more evident than in patients carrying a t(16;21)(p11;q22) translocation, which yields the fusion transcript.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!